3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Leukemia, Biphenotypic, Acute
7
Prostatic Neoplasms
4
Burkitt Lymphoma
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Myeloid, Acute
2
Recurrence
1
Prostate Cancer Metastatic
1
Neoplasms
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Lymphoma, T-Cell
1
Leukemia, Myelomonocytic, Juvenile
1
Down Syndrome
1
Interventions
Cyclophosphamide
28
Rituximab
24
fludarabine
15
fludarabine phosphate
13
Specimen Handling
12
obinutuzumab
10
ibrutinib
10
Magnetic Resonance Spectroscopy
10
Prednisone
8
Mycophenolic Acid
8
Doxorubicin
8
tocilizumab
7
polatuzumab vedotin
7
X-Rays
7
Whole-Body Irradiation
7
Phantoms, Imaging
7
Lenalidomide
7
Etoposide
7
Biopsy
7
glofitamab
6
Vincristine
6
Melphalan
6
Busulfan
6
Bendamustine Hydrochloride
6
venetoclax
5
pirtobrutinib
5
acalabrutinib
5
Peripheral Blood Stem Cell Transplantation
5
Nuclear Medicine Department, Hospital
5
Nivolumab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Non-Hodgkin
×
Hydrocortisone
×
90 days
×
Clear all
No trials found.